Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023

Upgrades

According to Morgan Stanley, the prior rating for First Solar Inc (NASDAQ:FSLR) was changed from Underweight to Equal-Weight. For the second quarter, First Solar had an EPS of $1.89, compared to year-ago quarter EPS of $0.52. At the moment, the stock has a 52-week-high of $232.00 and a 52-week-low of $115.66. First Solar closed at $186.48 at the end of the last trading period.

For MP Materials Corp (NYSE:MP), Northland Capital Markets upgraded the previous rating of Market Perform to Outperform. MP Materials earned $0.09 in the second quarter, compared to $0.41 in the year-ago quarter. The stock has a 52-week-high of $36.67 and a 52-week-low of $19.18. At the end of the last trading period, MP Materials closed at $21.53.

For MACOM Technology Solutions Holdings Inc (NASDAQ:MTSI), Craig-Hallum upgraded the previous rating of Hold to Buy. MACOM Technology Solns earned $0.54 in the third quarter, compared to $0.73 in the year-ago quarter. The current stock performance of MACOM Technology Solns shows a 52-week-high of $85.42 and a 52-week-low of $48.53. Moreover, at the end of the last trading period, the closing price was at $81.04.

For Cenovus Energy Inc (NYSE:CVE), Scotiabank upgraded the previous rating of Sector Perform to Sector Outperform. In the second quarter, Cenovus Energy showed an EPS of $0.33, compared to $0.93 from the year-ago quarter. The stock has a 52-week-high of $22.17 and a 52-week-low of $14.45. At the end of the last trading period, Cenovus Energy closed at $20.20.

B of A Securities upgraded the previous rating for CME Group Inc (NASDAQ:CME) from Underperform to Neutral. For the second quarter, CME Gr had an EPS of $2.30, compared to year-ago quarter EPS of $1.97. At the moment, the stock has a 52-week-high of $209.31 and a 52-week-low of $166.54. CME Gr closed at $202.53 at the end of the last trading period.

For ResMed Inc (NYSE:RMD), Needham upgraded the previous rating of Hold to Buy. In the fourth quarter, ResMed showed an EPS of $1.60, compared to $1.49 from the year-ago quarter. The current stock performance of ResMed shows a 52-week-high of $243.52 and a 52-week-low of $152.26. Moreover, at the end of the last trading period, the closing price was at $153.89.

Needham upgraded the previous rating for Semtech Corp (NASDAQ:SMTC) from Hold to Buy. For the first quarter, Semtech had an EPS of $0.02, compared to year-ago quarter EPS of $0.80. The current stock performance of Semtech shows a 52-week-high of $35.68 and a 52-week-low of $17.82. Moreover, at the end of the last trading period, the closing price was at $25.36.

TD Cowen upgraded the previous rating for Constellation Brands Inc (NYSE:STZ) from Market Perform to Outperform. Constellation Brands earned $2.91 in the first quarter, compared to $2.66 in the year-ago quarter. The stock has a 52-week-high of $273.65 and a 52-week-low of $208.12. At the end of the last trading period, Constellation Brands closed at $257.50.

According to Exane BNP Paribas, the prior rating for American Airlines Group Inc (NASDAQ:AAL) was changed from Neutral to Outperform. American Airlines Group earned $1.92 in the second quarter, compared to $0.76 in the year-ago quarter. The current stock performance of American Airlines Group shows a 52-week-high of $19.08 and a 52-week-low of $11.65. Moreover, at the end of the last trading period, the closing price was at $14.30.

For Toast Inc (NYSE:TOST), UBS upgraded the previous rating of Neutral to Buy. In the second quarter, Toast showed an EPS of $0.19, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $27.00 and a 52-week-low of $15.77. Toast closed at $21.67 at the end of the last trading period.

According to Baird, the prior rating for AeroVironment Inc (NASDAQ:AVAV) was changed from Neutral to Outperform. For the first quarter, AeroVironment had an EPS of $1.00, compared to year-ago quarter EPS of $0.10. The stock has a 52-week-high of $112.39 and a 52-week-low of $74.91. At the end of the last trading period, AeroVironment closed at $95.29.

According to B of A Securities, the prior rating for Adecoagro SA (NYSE:AGRO) was changed from Underperform to Neutral. Adecoagro earned $0.40 in the second quarter, compared to $0.40 in the year-ago quarter. The stock has a 52-week-high of $11.75 and a 52-week-low of $6.96. At the end of the last trading period, Adecoagro closed at $11.55.

According to Keybanc, the prior rating for Celanese Corp (NYSE:CE) was changed from Sector Weight to Overweight. For the second quarter, Celanese had an EPS of $2.17, compared to year-ago quarter EPS of $4.99. The current stock performance of Celanese shows a 52-week-high of $129.27 and a 52-week-low of $86.73. Moreover, at the end of the last trading period, the closing price was at $126.35.

See all analyst ratings upgrades.

Downgrades

For Plains GP Holdings LP (NASDAQ:PAGP), Citigroup downgraded the previous rating of Buy to Neutral. In the second quarter, Plains GP Holdings showed an EPS of $0.25, compared to $0.30 from the year-ago quarter. The current stock performance of Plains GP Holdings shows a 52-week-high of $16.28 and a 52-week-low of $10.45. Moreover, at the end of the last trading period, the closing price was at $16.05.

According to Longbow Research, the prior rating for Allegion PLC (NYSE:ALLE) was changed from Buy to Neutral. In the second quarter, Allegion showed an EPS of $1.76, compared to $1.37 from the year-ago quarter. The current stock performance of Allegion shows a 52-week-high of $128.36 and a 52-week-low of $87.73. Moreover, at the end of the last trading period, the closing price was at $111.14.

According to Wells Fargo, the prior rating for Enbridge Inc (NYSE:ENB) was changed from Overweight to Equal-Weight. For the second quarter, Enbridge had an EPS of $0.51, compared to year-ago quarter EPS of $0.53. The stock has a 52-week-high of $43.03 and a 52-week-low of $33.96. At the end of the last trading period, Enbridge closed at $35.29.

According to Exane BNP Paribas, the prior rating for Southwest Airlines Co (NYSE:LUV) was changed from Outperform to Neutral. In the second quarter, Southwest Airlines showed an EPS of $1.09, compared to $1.30 from the year-ago quarter. The current stock performance of Southwest Airlines shows a 52-week-high of $40.38 and a 52-week-low of $28.40. Moreover, at the end of the last trading period, the closing price was at $30.77.

According to UBS, the prior rating for Block Inc (NYSE:SQ) was changed from Buy to Neutral. In the second quarter, Block showed an EPS of $0.39, compared to $0.18 from the year-ago quarter. At the moment, the stock has a 52-week-high of $89.97 and a 52-week-low of $51.34. Block closed at $58.74 at the end of the last trading period.

Morgan Stanley downgraded the previous rating for Stem Inc (NYSE:STEM) from Overweight to Equal-Weight. In the second quarter, Stem showed an EPS of $0.26, compared to $0.21 from the year-ago quarter. The stock has a 52-week-high of $18.01 and a 52-week-low of $3.71. At the end of the last trading period, Stem closed at $5.01.

For Plains All American Pipeline LP (NASDAQ:PAA), Citigroup downgraded the previous rating of Buy to Neutral. Plains All American earned $0.25 in the second quarter, compared to $0.30 in the year-ago quarter. The stock has a 52-week-high of $15.49 and a 52-week-low of $10.17. At the end of the last trading period, Plains All American closed at $15.32.

According to Citigroup, the prior rating for Kinetik Holdings Inc (NYSE:KNTK) was changed from Buy to Neutral. For the second quarter, Kinetik Holdings had an EPS of $0.41, compared to year-ago quarter EPS of $0.06. The stock has a 52-week-high of $40.59 and a 52-week-low of $26.32. At the end of the last trading period, Kinetik Holdings closed at $33.86.

According to Goldman Sachs, the prior rating for Olin Corp (NYSE:OLN) was changed from Buy to Neutral. In the second quarter, Olin showed an EPS of $1.13, compared to $2.76 from the year-ago quarter. The current stock performance of Olin shows a 52-week-high of $64.70 and a 52-week-low of $41.34. Moreover, at the end of the last trading period, the closing price was at $51.11.

Brookline Capital downgraded the previous rating for Procaps Group SA (NASDAQ:PROC) from Buy to Hold. For the second quarter, Procaps Gr had an EPS of $0.27, compared to year-ago quarter EPS of $0.07. The current stock performance of Procaps Gr shows a 52-week-high of $8.41 and a 52-week-low of $3.68. Moreover, at the end of the last trading period, the closing price was at $3.94.

See all analyst ratings downgrades.

Initiations

Capital One initiated coverage on Cheniere Energy Inc (AMEX:LNG) with an Overweight rating. The price target for Cheniere Energy is set to $200.00. Cheniere Energy earned $5.61 in the second quarter, compared to $2.90 in the year-ago quarter. The current stock performance of Cheniere Energy shows a 52-week-high of $182.30 and a 52-week-low of $135.00. Moreover, at the end of the last trading period, the closing price was at $166.18.

Argus Research initiated coverage on Kenvue Inc (NYSE:KVUE) with a Hold rating. For the second quarter, Kenvue had an EPS of $0.32, compared to year-ago quarter EPS of $0.43. The current stock performance of Kenvue shows a 52-week-high of $27.80 and a 52-week-low of $22.36. Moreover, at the end of the last trading period, the closing price was at $22.61.

With a Buy rating, Lake Street initiated coverage on PetIQ Inc (NASDAQ:PETQ). The price target seems to have been set at $28.00 for PetIQ. PetIQ earned $0.46 in the second quarter, compared to $0.51 in the year-ago quarter. The current stock performance of PetIQ shows a 52-week-high of $20.86 and a 52-week-low of $6.69. Moreover, at the end of the last trading period, the closing price was at $18.19.

Oppenheimer initiated coverage on Freightos Ltd (NASDAQ:CRGO) with an Outperform rating. The price target for Freightos is set to $5.00. For the second quarter, Freightos had an EPS of $0.10, compared to year-ago quarter EPS of $0.77. The current stock performance of Freightos shows a 52-week-high of $31.15 and a 52-week-low of $1.85. Moreover, at the end of the last trading period, the closing price was at $2.70.

B. Riley Securities initiated coverage on Denali Therapeutics Inc (NASDAQ:DNLI) with a Buy rating. The price target for Denali Therapeutics is set to $38.00. Denali Therapeutics earned $1.30 in the second quarter, compared to $0.48 in the year-ago quarter. The current stock performance of Denali Therapeutics shows a 52-week-high of $34.78 and a 52-week-low of $21.74. Moreover, at the end of the last trading period, the closing price was at $23.84.

For The Trade Desk Inc (NASDAQ:TTD), William Blair initiated coverage, by setting the current rating at Outperform. In the second quarter, Trade Desk showed an EPS of $0.28, compared to $0.20 from the year-ago quarter. The current stock performance of Trade Desk shows a 52-week-high of $91.85 and a 52-week-low of $39.44. Moreover, at the end of the last trading period, the closing price was at $81.42.

With a Equal-Weight rating, Morgan Stanley initiated coverage on Penumbra Inc (NYSE:PEN). The price target seems to have been set at $265.00 for Penumbra. Penumbra earned $0.43 in the second quarter, compared to $0.01 in the year-ago quarter. The current stock performance of Penumbra shows a 52-week-high of $348.67 and a 52-week-low of $145.50. Moreover, at the end of the last trading period, the closing price was at $262.10.

HC Wainwright & Co. initiated coverage on Bitdeer Technologies Group (NASDAQ:BTDR) with a Buy rating. The price target for Bitdeer Technologies is set to $20.00. In the second quarter, Bitdeer Technologies showed an EPS of $0.36, compared to $0.14 from the year-ago quarter. The current stock performance of Bitdeer Technologies shows a 52-week-high of $14.60 and a 52-week-low of $4.60. Moreover, at the end of the last trading period, the closing price was at $12.75.

Barclays initiated coverage on Intapp Inc (NASDAQ:INTA) with an Overweight rating. The price target for Intapp is set to $43.00. The stock has a 52-week-high of $50.46 and a 52-week-low of $13.70. At the end of the last trading period, Intapp closed at $37.98.

HSBC initiated coverage on Laboratory Corp of America Holdings (NYSE:LH) with a Hold rating. The price target for Laboratory Corp is set to $210.00. For the second quarter, Laboratory Corp had an EPS of $3.42, compared to year-ago quarter EPS of $4.04. The current stock performance of Laboratory Corp shows a 52-week-high of $258.90 and a 52-week-low of $200.56. Moreover, at the end of the last trading period, the closing price was at $204.45.

HSBC initiated coverage on Zoetis Inc (NYSE:ZTS) with a Buy rating. The price target for Zoetis is set to $230.00. In the second quarter, Zoetis showed an EPS of $1.41, compared to $1.20 from the year-ago quarter. The current stock performance of Zoetis shows a 52-week-high of $194.99 and a 52-week-low of $124.35. Moreover, at the end of the last trading period, the closing price was at $190.43.

With a Hold rating, HSBC initiated coverage on UnitedHealth Group Inc (NYSE:UNH). The price target seems to have been set at $540.00 for UnitedHealth Group. In the second quarter, UnitedHealth Group showed an EPS of $6.14, compared to $5.57 from the year-ago quarter. The current stock performance of UnitedHealth Group shows a 52-week-high of $557.99 and a 52-week-low of $445.68. Moreover, at the end of the last trading period, the closing price was at $480.81.

HSBC initiated coverage on LivaNova PLC (NASDAQ:LIVN) with a Hold rating. The price target for LivaNova is set to $52.00. In the second quarter, LivaNova showed an EPS of $0.78, compared to $0.53 from the year-ago quarter. The stock has a 52-week-high of $59.86 and a 52-week-low of $40.26. At the end of the last trading period, LivaNova closed at $54.41.

HSBC initiated coverage on Johnson & Johnson (NYSE:JNJ) with a Hold rating. The price target for Johnson & Johnson is set to $175.00. Johnson & Johnson earned $2.80 in the second quarter, compared to $2.59 in the year-ago quarter. The stock has a 52-week-high of $181.02 and a 52-week-low of $150.11. At the end of the last trading period, Johnson & Johnson closed at $160.68.

With a Buy rating, HSBC initiated coverage on IQVIA Holdings Inc (NYSE:IQV). The price target seems to have been set at $260.00 for IQVIA Hldgs. In the second quarter, IQVIA Hldgs showed an EPS of $2.43, compared to $2.44 from the year-ago quarter. At the moment, the stock has a 52-week-high of $241.86 and a 52-week-low of $165.75. IQVIA Hldgs closed at $220.89 at the end of the last trading period.

HSBC initiated coverage on Gilead Sciences Inc (NASDAQ:GILD) with a Reduce rating. The price target for Gilead Sciences is set to $71.00. Gilead Sciences earned $1.34 in the second quarter, compared to $1.58 in the year-ago quarter. At the moment, the stock has a 52-week-high of $89.61 and a 52-week-low of $61.45. Gilead Sciences closed at $75.16 at the end of the last trading period.

HSBC initiated coverage on bluebird bio Inc (NASDAQ:BLUE) with a Buy rating. The price target for bluebird bio is set to $4.21. In the second quarter, bluebird bio showed an EPS of $0.67, compared to $1.36 from the year-ago quarter. At the moment, the stock has a 52-week-high of $8.58 and a 52-week-low of $2.78. bluebird bio closed at $3.71 at the end of the last trading period.

With a Buy rating, HSBC initiated coverage on Biogen Inc (NASDAQ:BIIB). The price target seems to have been set at $360.00 for Biogen. For the second quarter, Biogen had an EPS of $4.02, compared to year-ago quarter EPS of $5.25. At the moment, the stock has a 52-week-high of $334.58 and a 52-week-low of $194.48. Biogen closed at $266.29 at the end of the last trading period.

With a Buy rating, HSBC initiated coverage on Amgen Inc (NASDAQ:AMGN). The price target seems to have been set at $320.00 for Amgen. In the second quarter, Amgen showed an EPS of $5.00, compared to $4.65 from the year-ago quarter. The current stock performance of Amgen shows a 52-week-high of $296.63 and a 52-week-low of $211.71. Moreover, at the end of the last trading period, the closing price was at $254.01.

HSBC initiated coverage on Actinium Pharmaceuticals Inc (AMEX:ATNM) with a Buy rating. The price target for Actinium Pharma is set to $11.60. For the second quarter, Actinium Pharma had an EPS of $0.58, compared to year-ago quarter EPS of $0.33. At the moment, the stock has a 52-week-high of $15.11 and a 52-week-low of $5.87. Actinium Pharma closed at $6.53 at the end of the last trading period.

Raymond James initiated coverage on Fair Isaac Corp (NYSE:FICO) with an Outperform rating. The price target for Fair Isaac is set to $1007.00. Fair Isaac earned $5.66 in the third quarter, compared to $4.47 in the year-ago quarter. The stock has a 52-week-high of $915.48 and a 52-week-low of $391.84. At the end of the last trading period, Fair Isaac closed at $892.71.

With a Buy rating, JonesTrading initiated coverage on Prime Medicine Inc (NASDAQ:PRME). The price target seems to have been set at $20.00 for Prime Medicine. For the second quarter, Prime Medicine had an EPS of $0.47, compared to year-ago quarter EPS of $1.76. The stock has a 52-week-high of $21.60 and a 52-week-low of $11.07. At the end of the last trading period, Prime Medicine closed at $12.00.

Baird initiated coverage on Lucid Group Inc (NASDAQ:LCID) with a Neutral rating. The price target for Lucid Gr is set to $7.00. For the second quarter, Lucid Gr had an EPS of $0.40, compared to year-ago quarter EPS of $0.33. At the moment, the stock has a 52-week-high of $17.81 and a 52-week-low of $5.46. Lucid Gr closed at $6.30 at the end of the last trading period.

With an Outperform rating, Keefe, Bruyette & Woods initiated coverage on Federal Agricultural Mortgage Corp (NYSE:AGM). The price target seems to have been set at $220.00 for Federal Agricultural. For the second quarter, Federal Agricultural had an EPS of $3.86, compared to year-ago quarter EPS of $2.83. The current stock performance of Federal Agricultural shows a 52-week-high of $180.16 and a 52-week-low of $97.88. Moreover, at the end of the last trading period, the closing price was at $166.06.

Oppenheimer initiated coverage on Silk Road Medical Inc (NASDAQ:SILK) with an Outperform rating. The price target for Silk Road Medical is set to $30.00. For the second quarter, Silk Road Medical had an EPS of $0.35, compared to year-ago quarter EPS of $0.45. At the moment, the stock has a 52-week-high of $58.04 and a 52-week-low of $18.45. Silk Road Medical closed at $18.60 at the end of the last trading period.

Oppenheimer initiated coverage on LeMaitre Vascular Inc (NASDAQ:LMAT) with an Outperform rating. The price target for LeMaitre Vascular is set to $70.00. LeMaitre Vascular earned $0.37 in the second quarter, compared to $0.29 in the year-ago quarter. The stock has a 52-week-high of $68.67 and a 52-week-low of $41.79. At the end of the last trading period, LeMaitre Vascular closed at $55.29.

See all analyst ratings initiations.